Most people with atypical Alzheimer's may be ineligible for new therapies

MedicalXpress | авг 05, 2026

Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow the disease, according to a study published Aug. 5, 2026, in Neurology.